Targeting Lysyl Oxidase-like 2: A Therapeutic Strategy for Idiopathic Pulmonary Fibrosis with a Novel Indolizine Derivative
- DOI
- 10.3390/pharmaceutics18050554
- Published
- 2026-04-30
- Container
- Pharmaceutics
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/pharmaceutics18050554,
title = {Targeting Lysyl Oxidase-like 2: A Therapeutic Strategy for Idiopathic Pulmonary Fibrosis with a Novel Indolizine Derivative},
author = {Doo Hee Shim and Min Jung Kim and Hyeon Woo Chung and Mi Na Kim and Myung Hyun Sohn and Sunhee Lee and Ikyon Kim and Chun Geun Lee and Jack A. Elias and Jeon Han Park and Jae Myun Lee},
year = {2026},
journal = {Pharmaceutics},
doi = {10.3390/pharmaceutics18050554},
url = {https://doi.org/10.3390/pharmaceutics18050554}
}RIS
TY - JOUR TI - Targeting Lysyl Oxidase-like 2: A Therapeutic Strategy for Idiopathic Pulmonary Fibrosis with a Novel Indolizine Derivative AU - Doo Hee Shim AU - Min Jung Kim AU - Hyeon Woo Chung AU - Mi Na Kim AU - Myung Hyun Sohn AU - Sunhee Lee AU - Ikyon Kim AU - Chun Geun Lee AU - Jack A. Elias AU - Jeon Han Park AU - Jae Myun Lee PY - 2026 JO - Pharmaceutics DO - 10.3390/pharmaceutics18050554 UR - https://doi.org/10.3390/pharmaceutics18050554 ER -
APA
Shim, D. H., Kim, M. J., Chung, H. W., Kim, M. N., Sohn, M. H., Lee, S., Kim, I., Lee, C. G., Elias, J. A., Park, J. H., & Lee, J. M. (2026). Targeting Lysyl Oxidase-like 2: A Therapeutic Strategy for Idiopathic Pulmonary Fibrosis with a Novel Indolizine Derivative. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18050554
Source records
- crossref · retrieved 2026-09-25T06:59:01.030Z